SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-20-068485
Filing Date
2020-06-01
Accepted
2020-06-01 17:20:32
Documents
3
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A tm2014552d3_10qa.htm 10-Q/A 32506
2 EXHIBIT 31.1 tm2014552d3_ex31-1.htm EX-31.1 3896
3 EXHIBIT 31.2 tm2014552d3_ex31-2.htm EX-31.2 4003
  Complete submission text file 0001104659-20-068485.txt   41658
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33357 | Film No.: 20934635
SIC: 2836 Biological Products, (No Diagnostic Substances)